Phase I/II Study to Determine the Safety and Efficacy of Quercetin in COPD Patients
Phase of Trial: Phase I/II
Latest Information Update: 29 Dec 2016
At a glance
- Drugs Quercetin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Biomarker; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 24 Jul 2015 Planned End Date changed from 1 Dec 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
- 24 Jul 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov record.